The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Screening Tests for Gynaecological Cancer: Do They Increase Safety?
|
|
Author(s): Stamatios Petousis (2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Greece), Chrysoula Margioula-Siarkou (2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Greece), Georgia Margioula-Siarkou (2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Greece), Frederic Guyon (Gynaecologic Oncology Unit, Institut Bergonie, Bordeaux, France)and George Mavromatidis (2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Greece)
Copyright: 2021
Pages: 17
Source title:
Handbook of Research on Oncological and Endoscopical Dilemmas in Modern Gynecological Clinical Practice
Source Author(s)/Editor(s): Konstantinos Dinas (2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Greece), Stamatios Petousis (2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Greece), Matthias Kalder (Department of Obstetrics and Gynaecology, Philipps-University of Marburg, Germany)and George Mavromatidis (2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Greece)
DOI: 10.4018/978-1-7998-4213-2.ch003
Purchase
|
Abstract
The main screening tests that are used for the prevention and early diagnosis of gynaecological cancer are bimanual pelvic examination, transvaginal and transabdominal ultrasound, cervical cytology testing (Papanicolaou test), clinical breast examination, mammography, breast ultrasound, as well as newer diagnostic methods, such as HPV-DNA test and cancer biomarkers. Even though most of the above methods are widely used in everyday practice in gynaecology, it remains a subject for further discussion which of them should be used as screening tests and whether they increase safety in clinical approach of a patient, considering the danger of overdiagnosis and the role of screening test in personalized management of patients. The purpose of this chapter is to analyze the clinical benefit and safety of diagnostic methods related to prevention of various types of gynaecological cancer and in particular endometrial, ovarian, cervical, and breast cancer.
Related Content
|
Genevieve Z. Steiner-Lim, Madilyn Coles, Kayla Jaye, Najwa-Joelle Metri, Ali S. Butt, Katerina Christofides, Jackson McPartland, Zainab Al-Modhefer, Diana Karamacoska, Ethan Russo, Tim Karl.
© 2023.
47 pages.
|
|
Mohd Kashif, Mohammad Waseem, Poornima D. Vijendra, Ashok Kumar Pandurangan.
© 2023.
28 pages.
|
|
Courtney R. Acker, Rana R. Zeine.
© 2023.
27 pages.
|
|
Mahesh Pattabhiramaiah, Shanthala Mallikarjunaiah.
© 2023.
16 pages.
|
|
Dhairavi Shah, Dhaara Shah, Yara Mohamed, Danna Rosas, Alyssa Moffitt, Theresa Hearn Haynes, Francis Cortes, Taunjah Bell Neasman, Phani kumar Kathari, Ana Villagran, Rana R. Zeine.
© 2023.
28 pages.
|
|
Mohammad Uzair, Hammad Qaiser, Muhammad Arshad, Aneesa Zafar, Shahid Bashir.
© 2023.
23 pages.
|
|
Akila Muthuramalingam, Ashok Kumar Pandurangan, Subhamoy Banerjee.
© 2023.
17 pages.
|
|
|